P-66 Effects of Tamoxlfen Treatment on the Uterus and Ovary In Rats.(Proceedings of the 27th Annual Meeting)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2000-10-31
著者
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
Hisada Sigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Hisada Shigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Sato Atsuko
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
TANIFUJI Hisato
Safety & Pharmacokinetics Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
Iizuka Kazuhiro
Safety Resarch Department, Teikoku Hormone Mfg Co., Ltd.
-
Masuda Syuji
Teikoku Hormone Mfg. Co. Ltd.
-
Iizuka Kazuhiro
Teikoku Hormone Mfg. Co. Ltd.
-
NAGASHIMA Masako
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
MASUDA Shuji
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
MIMURA Yuuichi
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
NAKAYAMA Takaharu
Safety Res. Dept., Teikoku Hormone Mfg. Co., Ltd., of Kanagawa Pref.
-
TANIFUJI Hisato
Teikoku Hormone Mfg. Co., Ltd.
-
MASUDA Shuji
Teikoku Hormone Mfg. Co., Ltd.
-
Masuda Shuji
Teikoku Hormone Mfg. Co. Ltd.
-
Mimura Yuuichi
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
Tanifuji Hisato
Teikoku Hormone Mfg. Co. Ltd.
-
Nakayama Takaharu
Safety Res. Dept. Teikoku Hormone Mfg. Co. Ltd. Of Kanagawa Pref.
-
Nagashima Masako
Teikoku Hormone Mfg. Co. Ltd.
-
IIZUKA Kazuhiro
Teikoku Hormone Mfg. Co., Ltd.
関連論文
- Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
- Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- W1-2 ICH Survey on Immunotoxicity Data(WORKSHOP 1: CURRENT OF ICH GUIDANCE ON IMMUNOTOXICITY TEST)(Proceedings of the 31st Annual Meeting)
- PD1-2 Role of histopathology in immunotoxicity evaluation(PANEL DISCUSSION 1: RECENT STATUS AND FUTURE PERSPECTIVES OF IMMUNOTOXICOLOGY)(Proceedings of the 31st Annual Meeting)
- Relationship between the accumulation of p53 protein and the level of DNA damage induced by ENNG and mitomycin C in human hepatoma HepG2 cells(Mutagenicity, Carcinogenicity, Proceedings of the 32nd Annual Meeting)
- O-21 An investigation of a possible method of genotoxic screening using RT-PCR analysis of p53-regulated genes(MUTAGENICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Genotoxicity screening on an early phase of drug development using Ames miniscreen assay and in vitro micronucreus test (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Complete parallelism between enhancement of dopamine β -hydroxylase activity and increase in the rate of cell proliferation in adrenal medulla of male rats after reserpine treatment.
- Progesterone and medroxyprogesterone acetate accelerate the chronic nephropathy in female F344 rats
- Effects of in utero propylthiouracil exposure on the monoamine content of the rat fetus brain(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
- Effects of the p38 MAP kinase inhibitor SB203580 on the immune system of rats(Immune system, Allergy, Proceedings of the 32nd Annual Meeting)
- Tissue distribution of rat plasma released enzymes(Blood, Proceedings of the 32nd Annual Meeting)
- P-66 Effects of Tamoxlfen Treatment on the Uterus and Ovary In Rats.(Proceedings of the 27th Annual Meeting)
- P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
- 22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
- 21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
- Collaborative work on evaluation of ovarian toxicity : 1) Effects of 2- or 4-week repeated-dose administration and fertility studies with medroxyprogesterone acetate in female rats
- Immunolocalization of Androgen Receptor(AR)and Steroid 5 Alpha-Reductase Type II(5 Alpha-Reductase Type II)in Canine Prostate : -Effect of Antiandrogen, Chlormadinone Acetate(CMA)-
- P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
- P7-06 Time-course changes in morphology of the spleen and antibody production in rats after sheep red blood cells(SRBC)-immunization(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTAT
- 22B-09-3 Paclitaxel-induced neurotoxicity depends on the treatment schedule in mice.
- Histopathological Study of Female Beagle Dogs for Four Year Treatment with Subcutaneous Implantation of Chlormadinone Acetate (CMA)
- TZT-1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
- Effect of Antiandrogen, Chlormadinone Acetate (CMA), in Canine Spontaneous Benign Prostatic Hyperplasia (BPH)
- Induction of Apoptosis in Mice with B16 Melanoma by Treatment with the Antimicrotubule Agent TZT-1027
- Histopathological Study of the Effect of Antiandrogen, Chlormadinone Acetate (CMA), on Canine Spontaneous Benign Prostatic Hyperplasia (BPH)
- Immunohistochemical Studies in Canine Prostatic Hyperplasia : Effect of Antiandrogen
- Ultrastructural Study in Canine Prostatic Hyperplasia : Effect of Antiandrogen
- Immunolocalization of Androgen Receptor in Canine Prostatic Hyperplasia : Effect of Antiandrogen
- Immunoreactive Pit-1 Protein in Hyperplastic Pars Intermedia Induced by Calcitonin of the Rat Pituitary Gland
- Immunohistochemical Studies of Early Changes of Pituitary Glands Induced by Synthetic Salmon Calcitonin (sCT) jn Sprague-Dawley Rats : Experimental Models for the Human Alpha-Subunit-Producing Pituitary Adenomas
- Relationship between Prostatic Atrophy and Apoptosis in the Canine Spontaneous Benign Prostatic Hyperplasia (BPH) following Chlormadinone Acetate (CMA)
- Chlormadinone Acetate(CMA) Induces Apoptosis on Canine Spontaneous Benign Prostatic Hyperplasia(BPH)
- P-62 Histopathological and Immunohistochemical Studies of the Effect of Chlormadinone Acetate (CMA), on Canine Spontaneous Benign Prostatic Hyperplasia (BPH).(Proceedings of the 27th Annual Meeting)
- Histopathological and Immunohistochemical Studies in Female Beagle Dogs during Four Years Treatment with Implantation of Chlormadinone Acetate (CMA)